VOYA Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $851K | Buy |
90,855
+44,666
| +97% | +$418K | ﹤0.01% | 1642 |
|
|
2025
Q1 | $567K | Sell |
46,189
-2,642
| -5% | -$32.5K | ﹤0.01% | 1811 |
|
|
2024
Q4 | $646K | Sell |
48,831
-45,352
| -48% | -$600K | ﹤0.01% | 1829 |
|
|
2024
Q3 | $1.81M | Sell |
94,183
-89,466
| -49% | -$1.72M | ﹤0.01% | 1367 |
|
|
2024
Q2 | $3.77M | Sell |
183,649
-13,375
| -7% | -$275K | ﹤0.01% | 1116 |
|
|
2024
Q1 | $4.69M | Buy |
197,024
+30,991
| +19% | +$738K | ﹤0.01% | 1031 |
|
|
2023
Q4 | $3.59M | Buy |
166,033
+117,144
| +240% | +$2.53M | ﹤0.01% | 1130 |
|
|
2023
Q3 | $710K | Sell |
48,889
-81,729
| -63% | -$1.19M | ﹤0.01% | 1850 |
|
|
2023
Q2 | $2.73M | Buy |
130,618
+21,422
| +20% | +$448K | ﹤0.01% | 1231 |
|
|
2023
Q1 | $2.31M | Buy |
109,196
+14,683
| +16% | +$310K | ﹤0.01% | 1299 |
|
|
2022
Q4 | $2.41M | Hold |
94,513
| – | – | ﹤0.01% | 1257 |
|
|
2022
Q3 | $2.27M | Buy |
94,513
+75,293
| +392% | +$1.81M | ﹤0.01% | 1275 |
|
|
2022
Q2 | $370K | Buy |
19,220
+1,427
| +8% | +$27.5K | ﹤0.01% | 2028 |
|
|
2022
Q1 | $309K | Hold |
17,793
| – | – | ﹤0.01% | 2161 |
|
|
2021
Q4 | $389K | Sell |
17,793
-4
| -0% | -$87 | ﹤0.01% | 2161 |
|
|
2021
Q3 | $340K | Sell |
17,797
-155,289
| -90% | -$2.97M | ﹤0.01% | 2275 |
|
|
2021
Q2 | $2.97M | Buy |
173,086
+21,440
| +14% | +$368K | 0.01% | 1036 |
|
|
2021
Q1 | $3.39M | Sell |
151,646
-22,457
| -13% | -$502K | 0.01% | 977 |
|
|
2020
Q4 | $3.87M | Buy |
+174,103
| New | +$3.87M | 0.01% | 896 |
|
|
2020
Q2 | – | Sell |
-11,528
| Closed | -$126K | – | 2611 |
|
|
2020
Q1 | $126K | Hold |
11,528
| – | – | ﹤0.01% | 2287 |
|
|
2019
Q4 | $101K | Buy |
+11,528
| New | +$101K | ﹤0.01% | 2540 |
|